浅表放射治疗家族性良性慢性天疱疮
这项回顾性病例系列纳入13例平均病程24年的严重难治性家族性良性慢性天疱疮患者,在丹麦Bispebjerg大学医院皮肤科接受浅表放射治疗(每周期总剂量16 Gy)。62个治疗部位中56个(90%)达到长期缓解,平均随访32个月,治疗前平均皮肤病生活质量指数22分降至治疗后3分。
要点
- 13例严重难治性患者中9例(69%)首次周期后所有治疗部位完全缓解,另3例第二周期后完全缓解。
- 62个治疗部位中56个(90%)达长期完全缓解,成功治疗部位平均随访32(12)个月。
- 治疗伴随长达1个月的严重炎症,随后治疗区出现暂时性轻度色素沉着。
核心结论
- 该病例系列结果提示,浅表放射治疗与严重家族性良性慢性天疱疮患者的缓解相关,并可能对治疗部位皮肤提供长期改善。
研究设计与样本
- 回顾性病例系列,纳入13例严重家族性良性慢性天疱疮患者,平均(标准差)病程24(14)年,2015年1月至2021年4月在丹麦哥本哈根Bispebjerg大学医院皮肤科接受浅表放射治疗并随访。
主要发现
- 13例参与者平均(标准差)年龄52(18)岁,其中女性8例(62%)。
- 62个治疗部位中56个(90%)达到长期完全缓解,成功治疗部位平均(标准差)随访32(12)个月。
- 13例患者中9例(69%)在第一个治疗周期后所有治疗部位完全缓解,另3例在第二个浅表放射治疗周期后完全缓解。
- 1例患者2个治疗皮肤部位中1个部分缓解,但其病情改善程度使其选择不再接受重复治疗。
- 治疗前平均皮肤病生活质量指数评分为22(疾病对患者生活影响极大),治疗后降至平均3(对患者生活影响小)。
关键数值与推荐
- 完全长期缓解定义为至少12个月随访期间无复发。
- 浅表放射治疗方案为20千伏,8次2 Gy等于1个周期,每个治疗周期总剂量16 Gy。
- 患者接受1至6个治疗周期,每个周期治疗1至5个独立身体部位。
临床怎么用
- 作者认为浅表放射治疗与严重家族性良性慢性天疱疮患者的缓解相关,并可能对治疗部位皮肤提供长期改善。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Hailey-Hailey disease (HHD) is a chronic genodermatosis with recurrent vesicles and erosions mainly in the intertriginous areas. Hailey-Hailey disease severely affects patient quality of life. Standard treatments attempt to control the flares, but often do not result in long-term remission of the disease. OBJECTIVE: To describe outcomes of treatment with superficial radiotherapy (SR) for severe treatment-refractory HHD. DESIGN, SETTING, AND PARTICIPANTS: This retrospective case-series included 13 patients with severe HHD with a mean (SD) duration of 24 (14) years whose treatments with SR and follow-up were conducted at the Department of Dermatology at Bispebjerg University Hospital (Copenhagen, Denmark) from January 2015 to April 2021. INTERVENTIONS: Patients were treated with SR (20 kilovolt; 8 fractions of 2 gray was equal to 1 cycle) with a total dose of 16 gray in each treatment cycle. Patients received 1 to 6 treatment cycles with 1 to 5 separate body areas treated in each cycle. Sixty-two separate body areas were treated with SR. MAIN OUTCOMES AND MEASURES: Complete long-term remission, defined as no relapse during follow-up of at least 12 months. RESULTS: For the 13 participants (mean [SD] age, 52 [18] years; 8 women [62%]), 56 of 62 treated areas (90%) achieved long-term remission, and the mean (SD) follow-up was 32 (12) months for the successfully treated areas. Nine of 13 patients (69%) responded with complete remission of all treated areas after the first treatment cycle and an additional 3 patients experienced complete remission after the second SR cycle. One patient with partial remission in 1 of 2 treated skin areas experienced such an improvement in HHD that they chose to abstain from retreatment. The treatment was followed by severe inflammation lasting for up to 1 month followed by temporary slight hyperpigmentation of the treated areas. The average Dermatology Life Quality Index score before treatment with SR was 22 (the disease having extremely large effect on the patient's life) and decreased to an average of 3 (small effect on the patient's life) after treatment with SR. CONCLUSIONS AND RELEVANCE: The results of this case series suggest that treatment with SR was associated with remission in patients with severe HHD and may provide a long-term improvement of treated skin areas.
引用
- Wulf HC, Wiegell SR. Treatment of Familial Benign Chronic Pemphigus With Superficial Radiotherapy. JAMA Dermatol. 2022. PMID: 35019942. doi:10.1001/jamadermatol.2021.5491
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。